Adverum Biotechnlgs (NQ: ADVM )

2.240 USD -0.070 (-3.03%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2021 Add to My Watchlist

Price and Volume

Volume	1,302,876
Open	2.260
Bid (Size)	2.260 (1)
Ask (Size)	2.400 (15)
Prev. Close	2.310
Today's Range	2.160 - 2.350
52wk Range	2.065 - 14.79
Shares Outstanding	98,125,866
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs

August 23, 2021

Adverum Reports Second Quarter 2021 Results

August 05, 2021

Performance

YTD	-81.30%	-81.30%
1 Month	-4.68%	-4.68%
3 Month	-38.63%	-38.63%
6 Month	-79.32%	-79.32%
1 Year	-80.59%	-80.59%

More News

Interesting ADVM Call Options For January 2024

September 16, 2021

Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edema

July 22, 2021

12 Health Care Stocks Moving In Wednesday's After-Market Session

August 25, 2021

Where Adverum Biotechnologies Stands With Analysts

July 23, 2021

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 23, 2021

10 Biggest Price Target Changes For Friday

July 23, 2021

Adverum Stock Falls As It Stops Testing Ocular Gene Therapy Candidate In Diabetic Macular Edema Patients

July 23, 2021

Interesting ADVM Put And Call Options For March 2022

July 22, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Kane Republican

Adverum Biotechnlgs (NQ: ADVM )

Price and Volume

Top News

Performance

More News